Losartan Potassium

Product NDC: 13668-409
11-digit product format: 136680409
Labeler code: 13668
Product ID: 13668-409_dbd98acc-26f0-906a-e053-2995a90a0bc2
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Losartan Potassium
Dosage form: TABLET
Route: ORAL
Labeler: Torrent Pharmaceuticals Limited
Application: ANDA090467
Marketing category: ANDA
Marketing start: 2010-10-06
Marketing end: 0000-00-00
Substance: LOSARTAN POTASSIUM
Active strength: 50 mg/1
Pharmacologic classes: Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	13668-409		D	Discontinued by firm	2026-08-03
excluded package	package	13668-409	13668-409-10	D	Discontinued by firm	2026-08-03
excluded package	package	13668-409	13668-409-30	D	Discontinued by firm	2026-08-03
excluded package	package	13668-409	13668-409-90	D	Discontinued by firm	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	13668-409-30	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	13668-409-90	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	13668-409-10	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	13668-409-30	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	13668-409-90	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	13668-409-10	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	13668-409-30	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	13668-409-90	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	13668-409-10	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	13668-409-30	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	13668-409-90	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	13668-409-10	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	13668-409-30	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	13668-409-90	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	13668-409-10	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	13668-409-30	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	13668-409-90	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	13668-409-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	13668-409-30	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	13668-409-90	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	13668-409-10	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	13668-409-30	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	13668-409-90	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	13668-409-10	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	13668-409-30	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	13668-409-90	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	13668-409-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	13668-409-30	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	13668-409-90	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	13668-409-10	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	13668-409-30	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	13668-409-90	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	13668-409-10	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	13668-409-30	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	13668-409-90	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	13668-409-10	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A090467-001	LOSARTAN POTASSIUM	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06
A090467-002	LOSARTAN POTASSIUM	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06
A090467-003	LOSARTAN POTASSIUM	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A090467-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A090467-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A090467-003	AB	1	`74a2ff9319b5…`
2020-12-22 03:56 UTC	2020-12	A090467-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A090467-002	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A090467-003	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A090467-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A090467-002	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A090467-003	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A090467-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A090467-002	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A090467-003	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A090467-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A090467-002	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A090467-003	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A090467-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A090467-002	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A090467-003	AB	1	`ea99ee380514…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
0d341e63-aee5-498b-bf9a-b53a43963acf	Product name	1	20260105
de29c5c0-90ba-29da-d7ab-0500274708be	Product name	6	20241009
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
15b375b1-89c7-9594-80df-5a8c8864aee0	Product name	3	20180108

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
13668-409-10	EA - Each	13668-409	04ae8523-5636-4b5a-af90-a20f454e939b	1	2012-07-24
13668-409-30	EA - Each	13668-409	d1c634bb-b9b6-4203-b09c-9fbf9d90d85a	1	2012-07-24
13668-409-90	EA - Each	13668-409	3a534aad-3931-495b-85db-1f651f88cc5a	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LOSARTAN POTASSIUM	ACTIVE INGREDIENT	3ST302B24A	LOSARTAN POTASSIUM TABLET [TORRENT PHARMACEUTICALS LIMITED]	11
LOSARTAN	ACTIVE MOIETY	JMS50MPO89	LOSARTAN POTASSIUM TABLET [TORRENT PHARMACEUTICALS LIMITED]	11
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	LOSARTAN POTASSIUM TABLET [TORRENT PHARMACEUTICALS LIMITED]	11
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LOSARTAN POTASSIUM TABLET [TORRENT PHARMACEUTICALS LIMITED]	11
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LOSARTAN POTASSIUM TABLET [TORRENT PHARMACEUTICALS LIMITED]	11
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	LOSARTAN POTASSIUM TABLET [TORRENT PHARMACEUTICALS LIMITED]	11
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	LOSARTAN POTASSIUM TABLET [TORRENT PHARMACEUTICALS LIMITED]	11
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LOSARTAN POTASSIUM TABLET [TORRENT PHARMACEUTICALS LIMITED]	11
STARCH, PREGELATINIZED CORN	INACTIVE INGREDIENT	O8232NY3SJ	LOSARTAN POTASSIUM TABLET [TORRENT PHARMACEUTICALS LIMITED]	11
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LOSARTAN POTASSIUM TABLET [TORRENT PHARMACEUTICALS LIMITED]	11
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LOSARTAN POTASSIUM TABLET [TORRENT PHARMACEUTICALS LIMITED]	11
LOSARTAN POTASSIUM	ACTIVE INGREDIENT	3ST302B24A	LOSARTAN POTASSIUM TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4
LOSARTAN	ACTIVE MOIETY	JMS50MPO89	LOSARTAN POTASSIUM TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	LOSARTAN POTASSIUM TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LOSARTAN POTASSIUM TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LOSARTAN POTASSIUM TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	LOSARTAN POTASSIUM TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	LOSARTAN POTASSIUM TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LOSARTAN POTASSIUM TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4
STARCH, PREGELATINIZED CORN	INACTIVE INGREDIENT	O8232NY3SJ	LOSARTAN POTASSIUM TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LOSARTAN POTASSIUM TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LOSARTAN POTASSIUM TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4
LOSARTAN POTASSIUM	ACTIVE INGREDIENT	3ST302B24A	LOSARTAN POTASSIUM TABLET [PREFERRED PHARMACEUTICALS, INC.]	3
LOSARTAN POTASSIUM	ACTIVE INGREDIENT	3ST302B24A	LOSARTAN POTASSIUM TABLET [ST MARYS MEDICAL PARK PHARMACY]	3
LOSARTAN POTASSIUM	ACTIVE INGREDIENT	3ST302B24A	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	3
LOSARTAN	ACTIVE MOIETY	JMS50MPO89	LOSARTAN POTASSIUM TABLET [PREFERRED PHARMACEUTICALS, INC.]	3
LOSARTAN	ACTIVE MOIETY	JMS50MPO89	LOSARTAN POTASSIUM TABLET [ST MARYS MEDICAL PARK PHARMACY]	3
LOSARTAN	ACTIVE MOIETY	JMS50MPO89	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	3
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	3
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	LOSARTAN POTASSIUM TABLET [ST MARYS MEDICAL PARK PHARMACY]	3
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	LOSARTAN POTASSIUM TABLET [PREFERRED PHARMACEUTICALS, INC.]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LOSARTAN POTASSIUM TABLET [ST MARYS MEDICAL PARK PHARMACY]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LOSARTAN POTASSIUM TABLET [PREFERRED PHARMACEUTICALS, INC.]	3
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LOSARTAN POTASSIUM TABLET [ST MARYS MEDICAL PARK PHARMACY]	3
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	3
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	LOSARTAN POTASSIUM TABLET [ST MARYS MEDICAL PARK PHARMACY]	3
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	LOSARTAN POTASSIUM TABLET [PREFERRED PHARMACEUTICALS, INC.]	3
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	3
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	LOSARTAN POTASSIUM TABLET [ST MARYS MEDICAL PARK PHARMACY]	3
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	LOSARTAN POTASSIUM TABLET [PREFERRED PHARMACEUTICALS, INC.]	3
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LOSARTAN POTASSIUM TABLET [ST MARYS MEDICAL PARK PHARMACY]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LOSARTAN POTASSIUM TABLET [PREFERRED PHARMACEUTICALS, INC.]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LOSARTAN POTASSIUM TABLET [PREFERRED PHARMACEUTICALS, INC.]	3
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	LOSARTAN POTASSIUM TABLET [PREFERRED PHARMACEUTICALS, INC.]	3
STARCH, PREGELATINIZED CORN	INACTIVE INGREDIENT	O8232NY3SJ	LOSARTAN POTASSIUM TABLET [ST MARYS MEDICAL PARK PHARMACY]	3
STARCH, PREGELATINIZED CORN	INACTIVE INGREDIENT	O8232NY3SJ	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	3
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LOSARTAN POTASSIUM TABLET [ST MARYS MEDICAL PARK PHARMACY]	3
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LOSARTAN POTASSIUM TABLET [PREFERRED PHARMACEUTICALS, INC.]	3
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LOSARTAN POTASSIUM TABLET [ST MARYS MEDICAL PARK PHARMACY]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LOSARTAN POTASSIUM TABLET [PREFERRED PHARMACEUTICALS, INC.]	3
LOSARTAN POTASSIUM	ACTIVE INGREDIENT	3ST302B24A	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM) TABLET [AVPAK]	2
LOSARTAN POTASSIUM	ACTIVE INGREDIENT	3ST302B24A	LOSARTAN POTASSIUM TABLET [MAJOR PHARMACEUTICALS]	2
LOSARTAN POTASSIUM	ACTIVE INGREDIENT	3ST302B24A	LOSARTAN POTASSIUM TABLET [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
LOSARTAN	ACTIVE MOIETY	JMS50MPO89	LOSARTAN POTASSIUM TABLET [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
LOSARTAN	ACTIVE MOIETY	JMS50MPO89	LOSARTAN POTASSIUM TABLET [MAJOR PHARMACEUTICALS]	2
LOSARTAN	ACTIVE MOIETY	JMS50MPO89	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM) TABLET [AVPAK]	2
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	LOSARTAN POTASSIUM TABLET [MAJOR PHARMACEUTICALS]	2
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	LOSARTAN POTASSIUM TABLET [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM) TABLET [AVPAK]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LOSARTAN POTASSIUM TABLET [MAJOR PHARMACEUTICALS]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM) TABLET [AVPAK]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LOSARTAN POTASSIUM TABLET [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM) TABLET [AVPAK]	2
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM) TABLET [AVPAK]	2
HYDROXYPROPYL CELLULOSE (TYPE E)	INACTIVE INGREDIENT	66O7AQV0RT	LOSARTAN POTASSIUM TABLET [MAJOR PHARMACEUTICALS]	2
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	LOSARTAN POTASSIUM TABLET [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	LOSARTAN POTASSIUM TABLET [MAJOR PHARMACEUTICALS]	2
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	LOSARTAN POTASSIUM TABLET [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM) TABLET [AVPAK]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM) TABLET [AVPAK]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LOSARTAN POTASSIUM TABLET [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LOSARTAN POTASSIUM TABLET [MAJOR PHARMACEUTICALS]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LOSARTAN POTASSIUM TABLET [MAJOR PHARMACEUTICALS]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LOSARTAN POTASSIUM TABLET [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	LOSARTAN POTASSIUM TABLET [MAJOR PHARMACEUTICALS]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	LOSARTAN POTASSIUM TABLET [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
STARCH, PREGELATINIZED CORN	INACTIVE INGREDIENT	O8232NY3SJ	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM) TABLET [AVPAK]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LOSARTAN POTASSIUM TABLET [MAJOR PHARMACEUTICALS]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LOSARTAN POTASSIUM TABLET [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM) TABLET [AVPAK]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM) TABLET [AVPAK]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LOSARTAN POTASSIUM TABLET [MAJOR PHARMACEUTICALS]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LOSARTAN POTASSIUM TABLET [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
LOSARTAN POTASSIUM	ACTIVE INGREDIENT	3ST302B24A	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	1
LOSARTAN POTASSIUM	ACTIVE INGREDIENT	3ST302B24A	LOSARTAN POTASSIUM TABLET [LIFE LINE HOME CARE SERVICES, INC.]	1
LOSARTAN POTASSIUM	ACTIVE INGREDIENT	3ST302B24A	LOSARTAN POTASSIUM TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]	1
LOSARTAN	ACTIVE MOIETY	JMS50MPO89	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	1
LOSARTAN	ACTIVE MOIETY	JMS50MPO89	LOSARTAN POTASSIUM TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]	1
LOSARTAN	ACTIVE MOIETY	JMS50MPO89	LOSARTAN POTASSIUM TABLET [LIFE LINE HOME CARE SERVICES, INC.]	1
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	LOSARTAN POTASSIUM TABLET [LIFE LINE HOME CARE SERVICES, INC.]	1
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	1
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	LOSARTAN POTASSIUM TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LOSARTAN POTASSIUM TABLET [LIFE LINE HOME CARE SERVICES, INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LOSARTAN POTASSIUM TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	1
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LOSARTAN POTASSIUM TABLET [LIFE LINE HOME CARE SERVICES, INC.]	1
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	1
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LOSARTAN POTASSIUM TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]	1
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	LOSARTAN POTASSIUM TABLET [LIFE LINE HOME CARE SERVICES, INC.]	1
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	LOSARTAN POTASSIUM TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]	1
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	1
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	LOSARTAN POTASSIUM TABLET [LIFE LINE HOME CARE SERVICES, INC.]	1
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	1
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	LOSARTAN POTASSIUM TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LOSARTAN POTASSIUM TABLET [LIFE LINE HOME CARE SERVICES, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LOSARTAN POTASSIUM TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	1
STARCH, PREGELATINIZED CORN	INACTIVE INGREDIENT	O8232NY3SJ	LOSARTAN POTASSIUM TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]	1
STARCH, PREGELATINIZED CORN	INACTIVE INGREDIENT	O8232NY3SJ	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	1
STARCH, PREGELATINIZED CORN	INACTIVE INGREDIENT	O8232NY3SJ	LOSARTAN POTASSIUM TABLET [LIFE LINE HOME CARE SERVICES, INC.]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LOSARTAN POTASSIUM TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LOSARTAN POTASSIUM TABLET [LIFE LINE HOME CARE SERVICES, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LOSARTAN POTASSIUM TABLET [LIFE LINE HOME CARE SERVICES, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LOSARTAN POTASSIUM TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LOSARTAN POTASSIUM (LOSARTAN POTASSIUM TABLET) TABLET [DIRECT RX]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
3ST302B24A	LOSARTAN POTASSIUM	124750-99-8	LOSARTAN POTASSIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
979492	losartan potassium 50 MG Oral Tablet	PSN	25c32a8b-0389-2ed6-e054-00144ff8d46c	7
979492	losartan potassium 50 MG Oral Tablet	SCD	25c32a8b-0389-2ed6-e054-00144ff8d46c	7
979492	Losartan K+ 50 MG Oral Tablet	SY	25c32a8b-0389-2ed6-e054-00144ff8d46c	7
979492	Losartan Pot 50 MG Oral Tablet	SY	25c32a8b-0389-2ed6-e054-00144ff8d46c	7
979480	losartan potassium 100 MG Oral Tablet	PSN	02cdce82-4da9-4c34-89d9-43d542a40261	4
979492	losartan potassium 50 MG Oral Tablet	PSN	02cdce82-4da9-4c34-89d9-43d542a40261	4
979480	losartan potassium 100 MG Oral Tablet	SCD	02cdce82-4da9-4c34-89d9-43d542a40261	4
979492	losartan potassium 50 MG Oral Tablet	SCD	02cdce82-4da9-4c34-89d9-43d542a40261	4
979480	Losartan K+ 100 MG Oral Tablet	SY	02cdce82-4da9-4c34-89d9-43d542a40261	4
979492	Losartan K+ 50 MG Oral Tablet	SY	02cdce82-4da9-4c34-89d9-43d542a40261	4
979480	Losartan Pot 100 MG Oral Tablet	SY	02cdce82-4da9-4c34-89d9-43d542a40261	4
979492	Losartan Pot 50 MG Oral Tablet	SY	02cdce82-4da9-4c34-89d9-43d542a40261	4
979492	losartan potassium 50 MG Oral Tablet	PSN	f08333a1-35d7-446c-9ca2-41b2c4e533d8	1
979492	losartan potassium 50 MG Oral Tablet	PSN	c80b699a-5354-4f68-942f-6e92729eb8d8	1
979492	losartan potassium 50 MG Oral Tablet	PSN	4b0c8bda-2ee3-4e57-8637-aef38410ef21	1
979492	losartan potassium 50 MG Oral Tablet	SCD	4b0c8bda-2ee3-4e57-8637-aef38410ef21	1
979492	losartan potassium 50 MG Oral Tablet	SCD	c80b699a-5354-4f68-942f-6e92729eb8d8	1
979492	losartan potassium 50 MG Oral Tablet	SCD	f08333a1-35d7-446c-9ca2-41b2c4e533d8	1
979492	Losartan K+ 50 MG Oral Tablet	SY	c80b699a-5354-4f68-942f-6e92729eb8d8	1
979492	Losartan K+ 50 MG Oral Tablet	SY	f08333a1-35d7-446c-9ca2-41b2c4e533d8	1
979492	Losartan K+ 50 MG Oral Tablet	SY	4b0c8bda-2ee3-4e57-8637-aef38410ef21	1
979492	Losartan Pot 50 MG Oral Tablet	SY	c80b699a-5354-4f68-942f-6e92729eb8d8	1
979492	Losartan Pot 50 MG Oral Tablet	SY	4b0c8bda-2ee3-4e57-8637-aef38410ef21	1
979492	Losartan Pot 50 MG Oral Tablet	SY	f08333a1-35d7-446c-9ca2-41b2c4e533d8	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
13668-409-10	13668040910	1000 TABLET in 1 BOTTLE (13668-409-10)	1000 tablet	2010-10-06	0000-00-00	No	No	Current
13668-409-30	13668040930	30 TABLET in 1 BOTTLE (13668-409-30)	30 tablet	2010-10-06	0000-00-00	No	No	Current
13668-409-74	13668040974	100 TABLET in 1 CARTON (13668-409-74)	100 tablet	2010-10-06	0000-00-00	No	No	Current
13668-409-90	13668040990	90 TABLET in 1 BOTTLE (13668-409-90)	90 tablet	2010-10-06	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Losartan Potassium	Torrent Pharmaceuticals Limited \| Torrent Pharma, Inc.	2023-01-18	HUMAN PRESCRIPTION DRUG LABEL	18
Losartan Potassium	Bryant Ranch Prepack	2022-05-02	HUMAN PRESCRIPTION DRUG LABEL	9
Losartan Potassium	Major Pharmaceuticals	2021-09-14	HUMAN PRESCRIPTION DRUG LABEL	8
Losartan Potassium	Proficient Rx LP	2021-01-01	HUMAN PRESCRIPTION DRUG LABEL	3
Losartan Potassium	RPK Pharmaceuticals, Inc.	2020-12-24	HUMAN PRESCRIPTION DRUG LABEL	1
Losartan Potassium	Preferred Pharmaceuticals, Inc.	2020-07-14	HUMAN PRESCRIPTION DRUG LABEL	7
Losartan Potassium	REMEDYREPACK INC.	2020-05-07	HUMAN PRESCRIPTION DRUG LABEL	4
Losartan Potassium	REMEDYREPACK INC.	2020-04-07	HUMAN PRESCRIPTION DRUG LABEL	4
LOSARTAN POTASSIUM	Direct RX	2020-01-20	HUMAN PRESCRIPTION DRUG LABEL	7
Losartan Potassium	AvPAK	2020-01-20	HUMAN PRESCRIPTION DRUG LABEL	6
Losartan Potassium Tablets, USP	Lake Erie Medical DBA Quality Care Products LLC	2019-10-30	HUMAN PRESCRIPTION DRUG LABEL	7
Losartan Potassium	NCS HealthCare of KY, Inc dba Vangard Labs	2019-05-24	HUMAN PRESCRIPTION DRUG LABEL	5
Losartan Potassium	Legacy Pharmaceutical Packaging, LLC	2019-03-20	HUMAN PRESCRIPTION DRUG LABEL	5
Losartan Potassium Tablets, USP	St Marys Medical Park Pharmacy \| Torrent Pharmaceuticals Limited	2018-11-15	HUMAN PRESCRIPTION DRUG LABEL	6
Losartan Potassium	A-S Medication Solutions	2017-11-14	HUMAN PRESCRIPTION DRUG LABEL	4
Losartan Potassium	NuCare Pharmaceuticals,Inc.	2017-08-10	HUMAN PRESCRIPTION DRUG LABEL	1
Losartan Potassium	NuCare Pharmaceuticals,Inc.	2017-07-25	HUMAN PRESCRIPTION DRUG LABEL	1
Losartan Potassium	NuCare Pharmaceuticals, Inc.	2017-03-16	HUMAN PRESCRIPTION DRUG LABEL	1
Losartan Potassium	NuCare Pharmaceuticals, Inc.	2016-12-22	HUMAN PRESCRIPTION DRUG LABEL	1
LOSARTAN POTASSIUM	Direct RX	2015-06-29	HUMAN PRESCRIPTION DRUG LABEL	1
Losartan Potassium Tablets, USP	State of Florida DOH Central Pharmacy	2014-10-18	HUMAN PRESCRIPTION DRUG LABEL	4
Losartan Potassium Tablets, USP	Life Line Home Care Services, Inc.	2012-02-17	HUMAN PRESCRIPTION DRUG LABEL	1